GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Xvivo Perfusion AB (FRA:3XV) » Definitions » Pretax Margin %

Xvivo Perfusion AB (FRA:3XV) Pretax Margin % : 16.13% (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Xvivo Perfusion AB Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Xvivo Perfusion AB's Pre-Tax Income for the three months ended in Mar. 2024 was €2.65 Mil. Xvivo Perfusion AB's Revenue for the three months ended in Mar. 2024 was €16.44 Mil. Therefore, Xvivo Perfusion AB's pretax margin for the quarter that ended in Mar. 2024 was 16.13%.

The historical rank and industry rank for Xvivo Perfusion AB's Pretax Margin % or its related term are showing as below:

FRA:3XV' s Pretax Margin % Range Over the Past 10 Years
Min: -31.84   Med: 5.2   Max: 16.79
Current: 16.79


FRA:3XV's Pretax Margin % is ranked better than
80.37% of 815 companies
in the Medical Devices & Instruments industry
Industry Median: 0.05 vs FRA:3XV: 16.79

Xvivo Perfusion AB Pretax Margin % Historical Data

The historical data trend for Xvivo Perfusion AB's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xvivo Perfusion AB Pretax Margin % Chart

Xvivo Perfusion AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.40 -31.84 2.58 5.37 15.82

Xvivo Perfusion AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.78 7.40 0.65 42.10 16.13

Competitive Comparison of Xvivo Perfusion AB's Pretax Margin %

For the Medical Devices subindustry, Xvivo Perfusion AB's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xvivo Perfusion AB's Pretax Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Xvivo Perfusion AB's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Xvivo Perfusion AB's Pretax Margin % falls into.



Xvivo Perfusion AB Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Xvivo Perfusion AB's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=8.45/53.419
=15.82 %

Xvivo Perfusion AB's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=2.652/16.438
=16.13 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Xvivo Perfusion AB  (FRA:3XV) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Xvivo Perfusion AB Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Xvivo Perfusion AB's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Xvivo Perfusion AB (FRA:3XV) Business Description

Traded in Other Exchanges
Address
Massans gata 10, P.O. Box 53015, Gothenburg, SWE, SE-400 14
Xvivo Perfusion AB is a medical technology company dedicated to extending the life of all major organs so transplant teams around the world can save more lives. Its solutions allow clinicians and researchers to push the boundaries of transplantation medicine. It operates in three segments namely, Thoracic: Sales of lung and heart transplant products, Abdominal: Sales of liver and kidney transplant products. Services: Revenue from sales of services in organ recovery (carried out by subsidiary STAR Teams Inc.). The majority of revenue is derived from the Thoracic segment. Geographically, the majority is from the United States.

Xvivo Perfusion AB (FRA:3XV) Headlines

No Headlines